Analyst Price Targets — HUMA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 1, 2025 11:35 am | Swayampakula Ramakanth | H.C. Wainwright | $3.00 | $1.35 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Humacyte (HUMA) |
| October 13, 2025 11:19 am | — | UBS | $6.00 | $1.68 | TheFly | Humacyte price target lowered to $6 from $7 at BTIG |
| August 27, 2025 8:37 am | Matt Miksic | Barclays | $3.50 | $1.47 | TheFly | Humacyte initiated with an Overweight at Barclays |
| October 18, 2024 7:51 am | Matt O'Brien | Piper Sandler | $6.00 | $4.86 | StreetInsider | Piper Sandler Reiterates Neutral Rating on Humacyte (HUMA) |
| October 18, 2024 5:41 am | Ryan Zimmerman | BTIG | $10.00 | $4.86 | StreetInsider | BTIG Reiterates Buy Rating on Humacyte (HUMA) |
| December 20, 2022 10:49 am | Cowen Cowen | Cowen & Co. | $5.00 | $2.21 | Pulse 2.0 | Humacyte (HUMA) Stock Gets A $5 Price Target |
| May 15, 2022 9:11 pm | Matt O'Brien | Piper Sandler | $4.00 | $5.37 | TheFly | Humacyte downgraded to Underweight from Overweight at Piper Sandler |
Latest News for HUMA
Humacyte, Inc. (HUMA) closed the most recent trading day at $0.71, moving +2.31% from the previous trading session.
- Dr. Robert J. Kossmann has served as a prominent advocate for kidney disease patients in multiple roles including Executive Vice President and Chief Medical Officer for Fresenius Medical Care North America -
The latest trading day saw Humacyte, Inc. (HUMA) settling at $0.78, representing a -2.32% change from its previous close.
Humacyte, Inc. (HUMA) concluded the recent trading session at $0.62, signifying a -11.14% move from its prior day's close.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for HUMA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.